Frontier Bio: The phase II/III clinical trial of FB2001 for injection in patients with new coronavirus infection has been approved
Visit the original URL Frontier Bio announced on January 2 that at present, the company is actively accelerating the Phase II/III clinical trial of FB2001 for injection to treat hospitalized patients with new coronavirus infection and the Phase II clinical trial of FB2001 for aerosol inhalation to treat patients with mild and common coronavirus infection. […]